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Abstract
Background: We examined the outcome of debranching thoracic endovascular aortic repair (d-TEVAR) without
sternotomy for distal aortic arch aneurysm in patients aged ≥75 years.
Methods: Patients who underwent d-TEVAR or TAR for aortic arch aneurysm between 2008 and 2015 at our
hospital and aged ≥75 years were included. Age, sex, left ventricular ejection fraction, preoperative creatinine level,
diabetes, cerebrovascular disease, and chronic obstructive pulmonary disease were matched using PS.
Results: Among 74 patients (d-TEVAR: 51, TAR: 23), 17 patients in each group were matched. No difference in
surgical outcome was detected between the d-TEVAR and TAR groups, including 30-day death (0% vs. 0%), hospital
death (5.8% vs. 0%: p = 0.31) and incidence of cerebral infarction (5.8% vs. 7.6%: p = 0.27) as well as the long-term
outcomes of 5-year survival (92.8% vs. 74.8%: p = 0.30) and 5-year aorta-related event-free rate (88.2% vs. 100%:
p = 0.15). Average duration of ICU stay (1.3 ± 1.1 days vs. 5.6 ± 1.3 days: p = 0.025) and hospital stay (16.5 ± 5.2 days
vs. 37.7 ± 19.6 days: p = 0.017) were significantly shorter in the d-TEVAR group.
Conclusion: Our results indicated that d-TEVAR is less invasive without affecting long-term outcome up to 5 years.
Although the number of the patients included in the study was small, debranching TEVAR could be one of the
treatments of the choice in the elderly, especially with comorbidities.
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Introduction
Surgery for aortic arch aneurysm has been associated
with high mortality and serious complications. However,
recent advances in surgical procedures have remarkably
decreased the mortality rates and the incidence of post-
operative complications [1, 2]. Combined with advances
in surgical procedures, an aging of society has meant
that the number of surgery for the elderly has been in-
creasing. While the safety of surgery has been improving,
advanced age has been reported to be a risk factor for
surgery. Thus, careful examination of the treatment
strategy is required for the treatment of thoracic aortic
aneurysm in the elderly [3]. In recent years, treatment of
aneurysm has entered a new era after the endografts for
endovascular treatment became commercially available.
The safety of the endovascular treatment for the de-
scending thoracic aortic aneurysm and abdominal aortic
aneurysm has been established, and a favorable long-
term outcome has been reported [4, 5]. However, the
safety and long-term outcomes of the endovascular
treatment for aortic arch aneurysm remain controversial
as it requires the additional procedures, such as cervical
debranching. Since 2008, we have applied debranching
thoracic endovascular aortic repair (d-TEVAR) mainly
for selected patients. Essentially, we selected patients
with aortic arch aneurysm arising distal to left carotid
artery (distal arch aneurysm) and aged over 75 years old.
One of the problems of endovascular treatment for
aortic aneurysms is the increased aneurysm-related
mortality after 10 years as shown in EVAR trial 1 [6].
We decided this cut-off criteria of 75 years of age,
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because average life expectancy was about 10 years at
the age of 75 in Japan [7]. Even in elderly patients over
75 years old with distal arch aneurysm, total arch re-
placement (TAR) had to be selected, when enough prox-
imal landing zone could not be secured or landing zone
was considered to be shaggy. In this study, the early and
mid-term outcome of d-TEVAR was evaluated and com-
pared with that of total arch replacement through me-
dian sternotomy (TAR) as treatment procedures for




Patients who had aortic arch aneurysm arising distal to
left carotid artery (distal arch aneurysm) and underwent
d-TEVAR or TAR for degenerative aortic arch aneurysm
between 2008 and 2015 at our hospital and aged ≥75
years were included in this study. Patients were indicated
for surgery if exhibited a thoracic aortic aneurysm of
≥60mm. In principle, debranching TEVAR for aortic
arch aneurysm without sternotomy was performed, if
feasible, after introducing d-TEVAR in 2010, whereas
TAR was performed in patients with aneurysms extend-
ing to near the brachiocephalic artery so that sufficient
proximal landing zone was not assured. Patients who re-
ceived endovascular treatment with sternotomy or with
chimney technique were not included. A closed-chest
technique was adopted for all debranching TEVAR, and
bypass to the cervical branch or simple closing of the left
subclavian artery was simultaneously performed. TAR
was performed for patients in whom closed-chest deb-
ranching TEVAR is anatomically difficult to perform.
Patients who received endovascular aortic repair with
cervical debranching technique or simple closing of the
left subclavian artery when treating aortic arch aneurysm
were included in the debranching TEVAR group (d-
TEVAR), and patients who received TAR were included
in the TAR group.
This study was carried out in accordance with principles
outlined in the Declaration of Helsinki. It was conducted
after obtaining approval from the ethics committee of
Tottori University Faculty of Medicine.
Procedures of endovascular treatment
Treatment strategy was determined according to Zone
classification, in principle. The proximal side of the
endograft should be able to be fixed in zone 1 or 2 in
patients in the d-TEVAR group. At least 2 cm of the
landing zone to the proximal side was ensured. For graft
landing in zone 1, the left common carotid artery
(LCCA) and the left axillary artery (LAA) were bypassed
from the right axillary artery (RAA). As a basic policy,
the LCCA was tied at the proximal to the anastomosis
of the bypass and the origin of the left subclavian artery
was coiled after bypass (Fig. 1a). For graft landing in
zone 2, LCCA-LAA bypass, or RAA-LAA crossover by-
pass was performed. The origin of the left subclavian ar-
tery was also coiled after bypass in this case as a basic
policy (Fig. 1b).
Procedures of total arch replacement
A median sternotomy approach was employed for all
patients. Cardiopulmonary bypass was established with
venous drainage from the superior and inferior vena
cava and the blood return to the right axillary artery and
the either side of the femoral artery. Core body
temperature was cooled to ≤25 °C and total arch replace-
ment was performed with quadrifurcated graft under
selective cerebral perfusion and open distal technique.
Postoperative follow-up and data analysis
Patients were periodically followed-up as outpatients fol-
lowing surgery, and contrast enhanced or plain com-
puted tomography was performed once a year during
the follow-up period. If patients failed to visit hospital,
survival was confirmed via telephone.
Permanent neurological deficits (PND) were defined as
the presence of deficits at the time of hospital discharge.
Transient neurological deficits (TND) were defined as
the deficits that recovered by hospital discharge.
As endpoints, 30-day death, hospital death, duration in
ICU, incidence of PND, spinal cord disorder, duration in
hospital, transfer to a rehabilitation hospital, time until
home discharge, requirement for postoperative tubal feed-
ing, cumulative survival rate, and aorta-related event-free
rate were evaluated.
Statistical analysis
All numerical data are shown as averages ± standard
deviation (SD). All data were analyzed using PASW
Statistics ver. 24 (IBM SPSS Inc., Chicago, USA). The
unpaired t test was used for comparisons of continuous
variables. We utilized Kaplan-Meier curves and the log-
rank test to compare the endpoints. Differences with a P
value < 0.05 were considered statistically significant.
Owing to the non-randomized nature of the study,
and considering for significant differences in baseline
characteristics, propensity-score matching was used to
control for potential confounders of the treatment out-
come relationship. Propensity scores were calculated
using logistic regression with surgical procedure as the
dependent variable. The propensity score included 10
variables, including age, sex, hypertension, chronic ob-
structive pulmonary disease (FEV1.0% < 70%) (COPD), dia-
betes (treatment with insulin or oral hypoglycemic agents),
history of coronary disease (history of percutaneous coron-
ary intervention or coronary bypass), hemodialysis, previous
Shiraya et al. Journal of Cardiothoracic Surgery           (2020) 15:13 Page 2 of 7
sternotomy, history of cerebrovascular disease, and pre-
operative creatinine level. For each patient of debraching
TEVAR group, a propensity score-matched patient of TAR
group was selected (1:1) using the one-to-one nearest
neighbor method and no replacement.
Results
The total number of patients was 74, which included 51
patients in the d-TEVAR group and 23 patients in the
TAR group. Patients in the d-TEVAR group were signifi-
cantly older and significantly more patients were compli-
cated with COPD in the TEVAR group (Table 1). No
difference was observed in the surgical outcome of 30-
day death (1.9% vs. 0%: p = 0.49), hospital death (5.8% vs.
0%: p = 0.13), and the incidence of PND (3.9% vs. 4.3%:
p = 0.68) between the d-TEVAR and TAR groups. Aver-
age duration in ICU (2.1 ± 2.6 days vs. 4.8 ± 6.8 days: p =
0.016) and the average duration in hospital (17.8 ± 19.2
days vs. 35.6 ± 18.5 days: p = 0.0004) variables were sig-
nificantly increased in the TAR group, whereas transfer
to a rehabilitation hospital for recovery of activities of
daily living (ADL) was observed more often in the TAR
group (17.6% vs. 26.0%: p = 0.41). The time until home
discharge (median) was significantly increased in the
TAR group (34 days) compared with that in the d-
TEVAR group (13 days) (p = 0.016) (Table 2). No sig-
nificant difference was observed in the mid-term out-
comes of 5-year survival (53.0% vs. 63.0%: p = 0.47)
(Fig. 2a) and 5-year aorta-related event-free rate
(91.8% vs. 95.0%: p = 0.46) between the d-TEVAR and
TAR groups (Fig. 2b).
During matching of age, sex, hypertension, COPD, his-
tory of diabetes, coronary disease, hemodialysis, previous
sternotomy, and history of cerebrovascular disease,
Fig. 1 Representative image of 3-D computed tomography after debranching TEVAR. a Zone 1 landing. Right axillary artery - left common carotid
artery - left axillary artery bypass. b Zone 2 landing. Left common carotid artery – left axillary artery bypass and embolization of the origin of left
subclavian artery
Table 1 Patients characteristics
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preoperative creatinine level using PS, 17 patients each
of the d-TEVAR group (n = 51) and the TAR group (n =
23) were matched. Following matching, patient back-
grounds exhibited favorable matching (Table 3).
No difference was observed in the surgical outcome of
30-day death (0% vs. 0%), hospital death (5.8% vs. 0%:
p = 0.23), and the incidence of PND (5.8% vs. 5.8%: p =
0.76) between the d-TEVAR and TAR groups. The aver-
age duration in ICU (1.6 ± 1.5 days vs. 5.6 ± 7.8 days: p =
0.025) and the average duration in hospital (16.5 ± 16.2
days vs. 37.7 ± 19.6 days) were significantly increased in
the TAR group (p = 0.017), whereas transfer to a re-
habilitation hospital for the recovery of ADL was ob-
served significantly more often in the TAR group (5.8%
vs. 29.4%: p = 0.041). The time until home discharge
(median) was significantly increased in the TAR group
(34 days) compared with that in the d-TEVAR group
(12 days) (p = 0.011) (Table 4). No significant difference
was observed in the long-term outcomes of 5-year sur-
vival (92.8% vs. 74.8%: p = 0.30) (Fig. 3a) and 5-year
aorta-related event-free rate (88.2% vs. 100%: p = 0.15)
(Fig. 3b) between the d-TEVAR and TAR groups.
Discussion
In this study, the incidence of perioperative death and
cerebral infarction was low after debranching TEVAR
and TAR, and treatment of aortic arch aneurysm was
performed with relative safety in elderly individuals aged
≥75 years. Our indication of surgery was the aneurysm
exceeding 60 mm in diameter, which was a little bit lar-
ger than the current ESC guideline. In this study, we in-
creased the threshold due to the advanced age of the
patients. In bibliographic consideration of surgical treat-
ment for the elderly, Khaladj et al. examined 501 pa-
tients who underwent surgery using anterograde
selective cerebral perfusion for the ascending aortic
aneurysm and aortic arch aneurysm, and reported that
age was an independent risk factor for early death [3].
Okita et al. reported that operative mortality and com-
plication rates were significantly higher in patients in
their 70s and 80s, thus, thoracic aorta surgery appears to
be a risk for the elderly [8]. However, according to a
more recent report that showed a mortality rate of ~ 1%
in elective surgery, risk of surgery itself has been signifi-
cantly decreased [9]. Hiraoka et al. reported that age was
Table 2 Outcome after treatment
Debranching TEVAR (n = 51) TAR (n = 23) P value
30 days mortality. No. (%) 1 (1.9) 0 (0) 0.49
In-hospital death No. (%) 3 (5.9) 0 (0) 0.13
PND No. (%) 2 (3.9) 1 (4.3) 0.68
TND No. (%) 1 (1.9) 1 (4.3) 0.53
Spinal cord injury No. (%) 1 (1.9) 0 (0) 0.38
ICU stay (median) 2.1 ± 2.6 (1) 4.8 ± 6.8 (3) 0.016
Hospital Stay (median) 17.8 ± 19.2 (13) 35.6 ± 18.5 (35) 0.0004
Transfer to another hospital No. (%) 9 (17.6) 6 (26.0) 0.41
Total Hospitalization (median) 26.8 ± 30.3 (13) 47.2 ± 38.6 (34) 0.016
Fig. 2 Long-term results before propensity-score matching. a Survival rate after treatment of each group. b Aortic event free rate after treatment
of each group
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not a risk factor in aortic arch aneurysm [10]. Based on
these findings, surgery for thoracic aortic aneurysm in
elderly individuals aged ≤80 has been accepted [11]. In
our hospital, operative mortality and hospital mortality,
and the incidence of PND were relatively low (even in
the elderly), thus, it was indicated that surgery may be
performed safely in this population. However, PND was
reported as an independent predictor of postoperative
mortality in both d-TEVAR and TAR groups [12, 13];
this aspect probably reflects the influence of atheroscler-
otic changes in the aortic arch and neck vessels, rather
than procedural differences between the two groups.
However, the duration of ICU and hospital stay in the
elderly population evaluated in this study were signifi-
cantly shorter in the debranching TEVAR group, as com-
pared with those in the TAR group, and the number of
days required for home discharge was also significantly
shorter in the debranching TEVAR group. Therefore,
these results showed that more time is required for the re-
covery of ADL in the elderly in the TAR group, despite
the lower incidence of perioperative death and cerebral in-
farction. According to Lohse et al., postoperative quality
of life is significantly reduced if the duration in hospital
exceeds 20 days following ascending aorta replacement,
thus, it is indicated that a prolonged duration in hospital
results in the reduction of postoperative ADL [14].
In recent years, the number of surgeries performed in
the elderly has been increasing, thus, postoperative ADL
can be extremely important in considering treatment
strategy. ADL reduction is a serious problem in the eld-
erly, and the risk of developing life-threatening complica-
tions, including aspiration pneumonia, may be increased.
ADL reduction may be responsible for the lower cumula-
tive survival rate in the TAR group in this study, although
a significant difference was not observed. Therefore,
debranching TEVAR may be a highly useful procedure for
aortic arch aneurysm in the elderly, since shortening of
the postoperative time in hospital can be expected in this
procedure.
In discussion of the medium- and long-term results,
no significant difference was observed in the aorta-
related event rate between the d-TEVAR and TAR
groups. A previous report has indicated a higher re-
intervention rate after debranching TEVAR than after
TAR [15]. While a higher re-intervention rate was also
observed in the d-TEVAR group in this study, no aorta-
related deaths were observed. As far as the elderly are
concerned, overall survival was low because deaths in
Table 3 Patients characteristics after propensity-score matching
Debranching TEVAR (n = 17) TAR (n = 17) P value
Age (years) 76.9 ± 2.0 77.4 ± 2.2 0.52
Male (%) 14 (82.4%) 15 (88.2%) 0.62
Comorbidities
Hypertention No. (%) 17 (100%) 15 (88.2%) 0.089
COPD No. (%) 12 (70.5%) 11 (64.7%) 0.71
Diabetes Mellitus No. (%) 2 (11.8%) 4 (23.5%) 0.36
Coronary artery disease No. (%) 4 (23.5%) 5 (29.4%) 0.69
HemodialysisNo. (%) 0 (0%) 0 (0%)
History of CVA No. (%) 5 (29.4%) 6 (35.3%) 0.71
Preoperative creatinine (mg/dl) 0.88 ± 0.31 1.11 ± 0.41 0.07
Table 4 Outcome after propensity-score matching
Debranching TEVAR (n = 17) TAR (n = 17) P value
30 days mortality. No. (%) 0 (0) 0 (0)
In-hospital death No. (%) 1 (5.8) 0 (0) 0.23
PND No. (%) 1 (5.8) 1 (5.8) 0.76
TND No. (%) 0 (0) 1 (5.8) 0.50
Spinal cord injury No. (%) 0 (0) 0 (0)
ICU stay (median) 1.6 ± 1.5 (1) 5.6 ± 7.8 (3) 0.025
Hospital Stay (median) 16.5 ± 16.2 (12) 37.7 ± 19.7 (34) 0.0017
Transfer to another hospital No. (%) 1 (5.8) 5 (29.4) 0.041
Total Hospital Stay (median) 20.5 ± 23.9 (12) 52.6 ± 43.2 (34) 0.011
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the elderly were caused by multiple diseases. Hence, a
significant difference in aorta-related event rate, which is
considered to be often observed after debranching
TEVAR than after TAR, is unlikely to appear.
To perform endovascular treatment for thoracic aortic
arch aneurysm, whether the procedure can be anatomically
accepted is the absolute requirement, thus, it remains a
prominent concern that a procedure cannot be applied to
all patients. As debranching TEVAR without sternotomy
was selected in this study, cases requiring an approach to
the more proximal landing than zone 1 were not included
in the d-TEVAR group. This may be a limitation of this
study. Special procedures, including total debranching re-
quiring sternotomy, chimney graft technique and fenes-
trated or branching type endograft, are necessary for
treatment including zone 0. Previous studies have reported
that these respective procedures were related with higher
rate of complication like cerebral infarction, or higher
rate of endoleaks, and, thus, their reliability still re-
mains controversial [16]. However, as it is probable
that treatment for thoracic aortic arch aneurysm in
the elderly will benefit from endovascular treatment,
future advancement of the devices is required.
Conclusion
In consideration of the time required for the recovery of
ADL, debranching TEVAR could be one of the choices
for the treatment of aortic arch aneurysm in the elderly
aged 75 years or older, especially with comorbidities.
Limitations
Main limitations of this study are its retrospective
nature, small sample size and being performed in a
single-center. Although using a PS matching, definitive
conclusion may be difficult to be drawn due to small
number of patients studied. Further study with increased
number of patients should be warranted.
Abbreviations
ADL: Activities of daily living; COPD: Chronic obstructive pulmonary disease;
d-TEVAR: Thoracic endovascular treatment with debranching; LAA: The left
axillary artery; LCCA: The left common carotid artery; PND: Permanent
neurological deficit; PS: Propensity score; RAA: The right axillary artery;





SS, KY, HH have conceived and analyzed the study. SH, TO, YO, TK have
contributed to the collection of data. YN and MN have revised and corrected
the manuscript. All authors read and approved the final manuscript.
Funding
Not applicable.
Availability of data and materials
Supporting data are available upon request through the corresponding
author. Publication of raw data is not possible as it will conflict with our
privacy policy.
Ethics approval and consent to participate
This study was reviewed and approved by the local Ethics Committee of
Tottori University Faculty of Medicine and registered under 1601A115. All
methods were performed in accordance with the relevant guidelines and
regulations.
Consent for publication
Consent for the collection of data was obtained from the patients or legal
guardians.
Competing interests
The authors declare that they have no competing interests.
Received: 18 August 2019 Accepted: 2 January 2020
References
1. Kazui T, Yamashita K, Washiyama N, Terada H, Bashar AH, Suzuki K, et al.
Aortic arch replacement using selective cerebral perfusion. Ann Thorac
Surg. 2007;83:S796–8 discussion S824-S831.
2. Okita Y, Okada K, Omura A, Kano H, Minami H, Inoue T, et al. Total arch
replacement using antegrade cerebral perfusion. J Thorac Cardiovasc Surg.
2013;145(3 Suppl):S63–71.
3. Khaladj N, Shrestha M, Meck S, Peterss S, Kamiya H, Kallenbach K, et al.
Hypothermic circulatory arrest with selective antegrade cerebral perfusion
Fig. 3 Long-term results after propensity-score matching. a Survival rate of each group after propensity-score matching. b Aortic event free rate
of each group after propensity-score matching
Shiraya et al. Journal of Cardiothoracic Surgery           (2020) 15:13 Page 6 of 7
in ascending aortic and aortic arch surgery: a risk factor analysis for adverse
outcome in 501 patients. J Thorac Cardiovasc Surg. 2008;135(4):908–14.
4. Bicknell C, Powell JT. Aortic disease: thoracic endovascular aortic repair.
Heart. 2015;101(8):586–91. https://doi.org/10.1136/heartjnl-2014-306690
Epub 2015 Feb 12. Review.
5. Kayssi A, DeBord SA, Roche-Nagle G, Nguyen LL. Health-related quality-of-
life outcomes after open versus endovascular abdominal aortic aneurysm
repair. J Vasc Surg. 2015;62(2):491–8. https://doi.org/10.1016/j.jvs.2015.05.032
Review.
6. Patel R, Sweeting MJ, Powell JT, Greenhalgh RM. EVAR trial investigators.
Endovascular versus open repair of abdominal aortic aneurysm in 15-years’
follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a
randomized controlled trial. Lancet. 2016;388(10058):2366–74.
7. Japanese Ministry of Health, Labor and Welfare. Japanese population life
table. Available at: http://www.mhlw.go.jp/toukei/saikin/hw/life/life15/index.
html. Accessed 4 Dec 2019.
8. Okita Y, Ando M, Minatoya K, Tagusari O, Kitamura S, Nakajjma N, et al. Early
and long-term results of surgery for aneurysms of the thoracic aorta in
septuagenarians and octogenarians. Eur J Cardiothorac Surg. 1999;16(3):
317–23.
9. Okada K, Omura A, Kano H, Sakamoto T, Tanaka A, Inoue T, et al. Recent
advancements of total aortic arch replacement. J Thorac Cardiovasc Surg.
2012;144(1):139–45.
10. Hiraoka A, Chikazawa G, Totsugawa T, Kuinose M, Tamura K, Sakaguchi T, et al.
Open total aortic arch reconstruction for patients with advanced age in the
era of endovascular repair. J Thorac Cardiovasc Surg. 2014;148(1):77–82.
11. Kurazumi H, Mikamo A, Kudo T, Suzuki R, Takahashi M, Shirasawa B, et al.
Aortic arch surgery in octogenarians: is it justified? Eur J Cardiothorac Surg.
2014;46(4):672–7. https://doi.org/10.1093/ejcts/ezu056 Epub 2014 Feb 28.
12. Seike Y, Matsuda H, Fukuda T, Hori Y, Inoue Y, Omura A, et al. Is
debranching thoracic endovascular aortic repair acceptable as the first
choice for arch aneurysm in the elderly? Interact Cadiovasc Thorac Surg.
2019;29(1):101–8.
13. Seike Y, Matsuda H, Fukuda T, Inoue Y, Omura A, Uehara K, et al. Total arch
replacement versus debranching thoracic endovascular aortic repair for
aortic arch aneurysm: what indicates a high-risk patient for arch repair in
octogenarians? Gen Thorac Cardiovasc Surg. 2018;66(5):263–9.
14. Lohse F, Lang N, Schiller W, Roell W, Dewald O, Preusse CJ, et al. Quality of
life after replacement of the ascending aorta in patients with true
aneurysms. Tex Heart Inst J. 2009;36(2):104–10.
15. Iba Y, Minatoya K, Matsuda H, Sasaki H, Tanaka H, Oda T, et al. How should
aortic arch aneurysms be treated in the endovascular aortic repair era? A risk-
adjusted comparison between open and hybrid arch repair using propensity
score-matching analysis. Eur J Cardiothorac Surg. 2014;46(1):32–9.
16. Vallejo N, Rodriguez-Lopez JA, Heidari P, Wheatley G, Caparrelli D, Ramaiah
V, et al. Hybrid repair of thoracic aortic lesions for zone 0 and 1 in high-risk
patients. J Vasc Surg. 2012;55(2):318–25.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Shiraya et al. Journal of Cardiothoracic Surgery           (2020) 15:13 Page 7 of 7
